| abstract |
(57) Abstract: Prodrug compounds of formula (I) or (II), and compositions containing them, have a corresponding structure free of labile groups when administered to humans or other mammals. The duration of the active compound in plasma is increased compared to the compound having. In the above formula, n, P, Q, R 1 , R 2 ; and R 3 are as defined in the specification. The compounds can be used to treat a neurological condition such as epilepsy or pain. Embedded image |